Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 19;14(1):e240285.
doi: 10.1530/EC-24-0285. Print 2025 Jan 1.

Mildly elevated serum prolactin level may be a protective factor for preventing thickening of the carotid intima-media in patients with type 2 diabetes mellitus

Mildly elevated serum prolactin level may be a protective factor for preventing thickening of the carotid intima-media in patients with type 2 diabetes mellitus

Baoyu Zhang et al. Endocr Connect. .

Abstract

Objective: To evaluate the correlation between the serum prolactin (PRL) level and carotid intima-media thickness (CIMT) in patients with type 2 diabetes mellitus (T2DM).

Methods: In this study, 1,500 participants were divided into three groups based on the serum PRL level: hypoprolactinemia group (PRL ≤ 7 μg/L), normal PRL level group (7 μg/L < PRL ≤ 25 μg/L), and homeostatic functionally increased transient PRL (Ho-PRL) group (25 μg/L < PRL ≤ 100 μg/L). The independent-sample Kruskal-Wallis test was used to compare the CIMT among the three groups. The Spearman correlation test was used to examine the relationship between the CIMT, serum PRL level, and clinical data. Multivariate linear regression analysis was used to determine the independent factors that influence the CIMT.

Result: Individuals in the Ho-PRL group had a significantly lower CIMT compared to the hypoprolactinemia and normal PRL level groups (P < 0.001). The CIMT was positively correlated with age, systolic blood pressure (SBP), body mass index, duration of T2DM, and luteinizing hormone and follicle-stimulating hormone levels and negatively correlated with alanine transaminase and aspartate transaminase activities, estimated glomerular filtration rate, and PRL. Multivariate linear regression analysis revealed that only PRL was negatively associated with the CIMT, while age and SBP were positively associated with the CIMT.

Conclusion: In patients with T2DM, a PRL level within the mildly elevated range is negatively correlated with the CIMT. A mildly elevated serum PRL level may be a protective factor for preventing thickening of the carotid intima-media.

Keywords: carotid intima-media thickness; homeostatic functionally increased transient PRL; prolactin; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work.

Figures

Figure 1
Figure 1
Data cleaning flowchart. MMC: the National Metabolic Management Center; PRL: prolactin.
Figure 2
Figure 2
Comparison of the CIMT in the Hy-PRL, N-PRL, and Ho-PRL groups. (A) Comparing the differences of the CIMT in the Hy-PRL, N-PRL, and Ho-PRL groups among all subjects; (B) comparing the differences of the CIMT in the Hy-PRL, N-PRL, and Ho-PRL groups among male subjects; and (C) comparing the difference of the CIMT in the Hy-PRL, N-PRL, and Ho-PRL groups among female subjects.

Similar articles

Cited by

References

    1. Vos T, Abbafati C, Abbas KM, et al. . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020. 396 1204–1222. (10.1016/s0140-6736(20)30925-9) - DOI - PMC - PubMed
    1. Vaduganathan M, Mensah GA, Turco JV, et al. . The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 2022. 80 2361–2371. (10.1016/j.jacc.2022.11.005) - DOI - PubMed
    1. Gregg EW, Sattar N & Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol 2016. 4 537–547. (10.1016/s2213-8587(16)30010-9) - DOI - PubMed
    1. Carracher AM, Marathe PH & Close KL. International Diabetes Federation 2017. J Diabetes 2018. 10 353–356. (10.1111/1753-0407.12644) - DOI - PubMed
    1. Dal Canto E, Ceriello A, Rydén L, et al. . Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019. 26 25–32. (10.1177/2047487319878371) - DOI - PubMed

LinkOut - more resources